NEWPARK RESOURCES INC (NR)

US6517185046 - Common Stock

7.25  -0.37 (-4.86%)

After market: 7.25 0 (0%)

Fundamental Rating

4

NR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 59 industry peers in the Energy Equipment & Services industry. NR has a great financial health rating, but its profitability evaluates not so good. NR does not seem to be growing, but still is valued expensively.



2

1. Profitability

1.1 Basic Checks

In the past year NR was profitable.
NR had a positive operating cash flow in the past year.
NR had negative earnings in 4 of the past 5 years.
In multiple years NR reported negative operating cash flow during the last 5 years.

1.2 Ratios

NR's Return On Assets of -39.05% is on the low side compared to the rest of the industry. NR is outperformed by 96.61% of its industry peers.
NR's Return On Equity of -48.08% is on the low side compared to the rest of the industry. NR is outperformed by 89.83% of its industry peers.
With a decent Return On Invested Capital value of 9.30%, NR is doing good in the industry, outperforming 69.49% of the companies in the same industry.
Industry RankSector Rank
ROA -39.05%
ROE -48.08%
ROIC 9.3%
ROA(3y)-1.35%
ROA(5y)-3.37%
ROE(3y)-2.31%
ROE(5y)-5.17%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

NR's Profit Margin has declined in the last couple of years.
NR has a Operating Margin (8.02%) which is in line with its industry peers.
NR's Operating Margin has declined in the last couple of years.
NR's Gross Margin of 24.13% is in line compared to the rest of the industry. NR outperforms 45.76% of its industry peers.
NR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.02%
PM (TTM) N/A
GM 24.13%
OM growth 3YN/A
OM growth 5Y-4.51%
PM growth 3YN/A
PM growth 5Y-10.71%
GM growth 3Y67.42%
GM growth 5Y-0.53%

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NR is still creating some value.
NR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for NR has been reduced compared to 5 years ago.
The debt/assets ratio for NR has been reduced compared to a year ago.

2.2 Solvency

NR has an Altman-Z score of 6.43. This indicates that NR is financially healthy and has little risk of bankruptcy at the moment.
NR has a better Altman-Z score (6.43) than 96.61% of its industry peers.
NR has a debt to FCF ratio of 0.35. This is a very positive value and a sign of high solvency as it would only need 0.35 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.35, NR belongs to the top of the industry, outperforming 91.53% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that NR is not too dependend on debt financing.
NR has a better Debt to Equity ratio (0.02) than 86.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.35
Altman-Z 6.43
ROIC/WACC1.05
WACC8.85%

2.3 Liquidity

NR has a Current Ratio of 2.29. This indicates that NR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of NR (2.29) is better than 64.41% of its industry peers.
A Quick Ratio of 2.00 indicates that NR should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 2.00, NR is doing good in the industry, outperforming 74.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.29
Quick Ratio 2

1

3. Growth

3.1 Past

NR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.21%.
The Earnings Per Share has been decreasing by -3.04% on average over the past years.
The Revenue for NR has decreased by -38.43% in the past year. This is quite bad
Measured over the past years, NR shows a decrease in Revenue. The Revenue has been decreasing by -4.56% on average per year.
EPS 1Y (TTM)-21.21%
EPS 3YN/A
EPS 5Y-3.04%
EPS Q2Q%-100%
Revenue 1Y (TTM)-38.43%
Revenue growth 3Y15.02%
Revenue growth 5Y-4.56%
Sales Q2Q%-77.73%

3.2 Future

The Earnings Per Share is expected to grow by 16.17% on average over the next years. This is quite good.
The Revenue is expected to decrease by -28.57% on average over the next years. This is quite bad
EPS Next Y33.9%
EPS Next 2Y11.69%
EPS Next 3Y16.17%
EPS Next 5YN/A
Revenue Next Year-63.28%
Revenue Next 2Y-43.4%
Revenue Next 3Y-28.57%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 27.88, which means the current valuation is very expensive for NR.
64.41% of the companies in the same industry are cheaper than NR, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.73. NR is around the same levels.
NR is valuated rather expensively with a Price/Forward Earnings ratio of 19.37.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NR indicates a slightly more expensive valuation: NR is more expensive than 67.80% of the companies listed in the same industry.
NR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.83.
Industry RankSector Rank
PE 27.88
Fwd PE 19.37

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NR indicates a slightly more expensive valuation: NR is more expensive than 66.10% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 15.91
EV/EBITDA 8.6

4.3 Compensation for Growth

NR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NR's earnings are expected to grow with 16.17% in the coming years.
PEG (NY)0.82
PEG (5Y)N/A
EPS Next 2Y11.69%
EPS Next 3Y16.17%

0

5. Dividend

5.1 Amount

No dividends for NR!.
Industry RankSector Rank
Dividend Yield N/A

NEWPARK RESOURCES INC

NYSE:NR (12/18/2024, 8:04:00 PM)

After market: 7.25 0 (0%)

7.25

-0.37 (-4.86%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners87.81%
Inst Owner Change2.16%
Ins Owners8.6%
Ins Owner Change0.41%
Market Cap627.13M
Analysts83.33
Price Target11.48 (58.34%)
Short Float %1.51%
Short Ratio1.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-24.84%
Min EPS beat(2)-100%
Max EPS beat(2)50.33%
EPS beat(4)2
Avg EPS beat(4)-5.34%
Min EPS beat(4)-100%
Max EPS beat(4)76.52%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-9.08%
Min Revenue beat(2)-20.8%
Max Revenue beat(2)2.64%
Revenue beat(4)1
Avg Revenue beat(4)-6.71%
Min Revenue beat(4)-20.8%
Max Revenue beat(4)2.64%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-25.2%
EPS NQ rev (3m)-25.2%
EPS NY rev (1m)16.42%
EPS NY rev (3m)5.41%
Revenue NQ rev (1m)-67.59%
Revenue NQ rev (3m)-67.59%
Revenue NY rev (1m)-40.42%
Revenue NY rev (3m)-60.32%
Valuation
Industry RankSector Rank
PE 27.88
Fwd PE 19.37
P/S 1.26
P/FCF 15.91
P/OCF 7.99
P/B 1.98
P/tB 2.43
EV/EBITDA 8.6
EPS(TTM)0.26
EY3.59%
EPS(NY)0.37
Fwd EY5.16%
FCF(TTM)0.46
FCFY6.29%
OCF(TTM)0.91
OCFY12.52%
SpS5.74
BVpS3.66
TBVpS2.98
PEG (NY)0.82
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.05%
ROE -48.08%
ROCE 11.77%
ROIC 9.3%
ROICexc 10.65%
ROICexgc 13.27%
OM 8.02%
PM (TTM) N/A
GM 24.13%
FCFM 7.93%
ROA(3y)-1.35%
ROA(5y)-3.37%
ROE(3y)-2.31%
ROE(5y)-5.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y0.24%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.7%
OM growth 3YN/A
OM growth 5Y-4.51%
PM growth 3YN/A
PM growth 5Y-10.71%
GM growth 3Y67.42%
GM growth 5Y-0.53%
F-Score6
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.35
Debt/EBITDA 0.08
Cap/Depr 131.66%
Cap/Sales 7.86%
Interest Coverage 6.58
Cash Conversion 112.9%
Profit Quality N/A
Current Ratio 2.29
Quick Ratio 2
Altman-Z 6.43
F-Score6
WACC8.85%
ROIC/WACC1.05
Cap/Depr(3y)72.72%
Cap/Depr(5y)69.63%
Cap/Sales(3y)3.64%
Cap/Sales(5y)3.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.21%
EPS 3YN/A
EPS 5Y-3.04%
EPS Q2Q%-100%
EPS Next Y33.9%
EPS Next 2Y11.69%
EPS Next 3Y16.17%
EPS Next 5YN/A
Revenue 1Y (TTM)-38.43%
Revenue growth 3Y15.02%
Revenue growth 5Y-4.56%
Sales Q2Q%-77.73%
Revenue Next Year-63.28%
Revenue Next 2Y-43.4%
Revenue Next 3Y-28.57%
Revenue Next 5YN/A
EBIT growth 1Y-19.82%
EBIT growth 3YN/A
EBIT growth 5Y-8.86%
EBIT Next Year41.61%
EBIT Next 3Y26.34%
EBIT Next 5YN/A
FCF growth 1Y160.47%
FCF growth 3Y20.95%
FCF growth 5Y31.06%
OCF growth 1Y275.22%
OCF growth 3Y21.47%
OCF growth 5Y9.54%